Literature DB >> 31054908

Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013-2017.

Erica T Warner1, Christopher S Lathan2.   

Abstract

Despite demonstrated reduction in lung cancer mortality, lung cancer screening uptake has been low. We investigated differences in discussions with physicians about lung cancer screening and awareness using repeated cross-sectional data from three cycles [4.2 (2013); 4.4(2014) and 5.1 (2017)] of the Health Information National Trends Survey. We included 4207 respondents age 55 to 80 who responded to this question: 'In the past year, have you talked with your doctor about having a test to check for lung cancer?'. We used logistic regression accounting for complex sample weighting to generate multivariable adjusted odds ratios (ORs) and 95% confidence intervals (CIs). The proportion of participants reporting lung cancer screening discussions was low and did not increase over time. In the most recent cycle, 15.7% of current smokers and 9.9% of former smokers said they had discussed screening. Compared to males, females were 32% less likely to report a lung cancer screening discussion (OR: 0.68, 95% CI: 0.50-0.93) and the association was strongest among non-Hispanic White females. Estimates were similar among never (OR: 0.72, 95% CI: 0.43-1.20), current (OR: 0.73, 95% CI: 0.39-1.36), and former (OR: 0.66, 95% CI: 0.40-1.10) smokers. Females were 32% less likely than males to be aware of a lung cancer screening test (OR: 0.68, 95% CI: 0.47-0.99) and this association was strongest for non-Hispanic Black females (OR: 0.38, 95% CI: 0.19-0.77). Too few providers have discussed lung cancer screening with potentially eligible patients, particularly female patients. Further research is needed to evaluate possible causes for this finding.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Awareness; Communication; Lung neoplasms; Mass screening; Sex

Mesh:

Year:  2019        PMID: 31054908     DOI: 10.1016/j.ypmed.2019.05.001

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  4 in total

1.  Promoting Clinical Conversations about Lung Cancer Screening: Exploring the Role of Perceived Online Social Support.

Authors:  Samantha R Paige; Ramzi G Salloum; Janice L Krieger; Maribeth Williams; Wei Xue; Babette Brumback
Journal:  J Health Commun       Date:  2020-10-29

2.  Worry About the Future Health Issues of Smoking and Intention to Screen for Lung Cancer With Low-Dose Computed Tomography.

Authors:  Hermine Poghosyan; Susan Mello; Kathryn N Robinson; Andy S L Tan
Journal:  Cancer Nurs       Date:  2022 Jan-Feb 01       Impact factor: 2.592

3.  Lung cancer mortality in Europe and the USA between 2000 and 2017: an observational analysis.

Authors:  Chinmay Jani; Dominic C Marshall; Harpreet Singh; Richard Goodall; Joseph Shalhoub; Omar Al Omari; Justin D Salciccioli; Carey C Thomson
Journal:  ERJ Open Res       Date:  2021-12-27

4.  miRNA-199a-5p/SLC2A1 axis regulates glucose metabolism in non-small cell lung cancer.

Authors:  Yikun Xu; Binshu Chai; Xianyi Wang; Zong Wu; Zhitao Gu; Xiaomin Liu; Yiqi Zhao; Tangbing Chen; Zhongliang Ma; Qiangling Sun
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.